Effect of Albuminuria on the State of Plasma Hemostasis in Patients with Essential Hypertension
Journal Title: Нирки - Year 2016, Vol 3, Issue 17
Abstract
In recent decades, numerous scientific works are devoted to the study of the clinical and prognostic significance of albuminuria, methods of its detection, as well as treatment measures aimed at controlling this pathological condition. The objective of this work was to determine the features of changes of plasma hemostasis in patients with essential hypertension (EH), depending on the presence of albuminuria. Materials and methods. We have exa-mined 113 people: 14 apparently healthy ones (group 1, controls), 41 patients with EH stage II with concomitant albuminuria (group 2), 58 patients with EH stage II without concomitant albuminuria (group 3). We have conducted laboratory studies: measured activated partial thromboplastin time, prothrombin index, thrombin time, fibrinogen, soluble fibrin monomer complex (SFMC), time of XIIa-dependent fibrinolysis, antithrombin III, protein C. Results. There was found an increased content of SFMC, which in patients from group 3 was 135 % higher, and in patients of group 2 — 247 % higher than reference values. At that, in patients with albuminuria, this index was much higher even than in individuals with EH without albuminuria — exceeded by 48 %. Time of XIIa-dependent fibrinolysis in both group 2 and 3 was much longer than normal one. Expressed changes occurred in the system of natural anticoagulants, which were statistically significant in relation to the control group only in patients with albuminuria, and in the group of patients without albuminuria they were not significantly different from the control group. Conclusions. Patients with essential hypertension, regardless of the severity of albuminuria, showed a significant inhibition of fibrinolytic activity of the blood and activation of the last units of blood clotting — fibrin formation. Albuminuria was associated with a more significant activation of fibrin formation and was combined with inhibition of own anticoagulant activity of the blood, as evidenced by the decrease in the content of antithrombin III and protein C.
Authors and Affiliations
A. I. Pastushyna, O. M. Plenova
Keywords
Related Articles
- EP ID EP208328
- DOI 10.22141/2307-1257.3.17.2016.76537
- Views 107
- Downloads 0
Application of Imupret in the Complex Treatment of Chronic Glomerulonephritis in Children
The article presents data on clinical efficacy, tolerability and safety of immunoprophylaxis of acute respiratory viral infections and exacerbation of episodes of acute inflammatory diseases of the upper respiratory trac...
Kidney Damage in Solid Tumors
The article describes in detail the clinical case of the onset of breast cancer with nephrotic syndrome.
Kidney Aspects of the Lung Cancer
Metastases in the kidney, perirenal retroperitoneal lymph nodes and adrenal glands occur in 2, 2, and 3 % of patients with lung cancer, respectively, and acute tubulointerstitial nephritis develops in 6 % of cases of rad...
Active Follow-up in Patients with Localized Prostate Cancer: Evaluation of Long-term Results
Among the clinical recommendations one of the standard approaches in the treatment of prostate cancer is active follow-up. For 13 years, under the supervision there were 85.7 % of patients. Overall 3-, 5- and 7-year surv...
24-hour blood pressure profile in children with chronic pyelonephritis and chronic kidney disease stages I–III
Background. Blood pressure (BP) monitoring is important for the management of patients with chronic kidney disease (CKD), both for the conventional cardiovascular risk reduction and long-term preservation of kidney funct...